Search Medical Condition
Please enter condition
Please choose location from dropdown

London, India Clinical Trials

A listing of London, India clinical trials actively recruiting patients volunteers.

RESULTS

Found (438) clinical trials

A Study to Evaluate OPTI-BIOME Bacillus Subtilis MB40 on Abdominal Discomfort Gas and Bloating in a Healthy Population

The purpose of this study is to investigate the effects of OPTI-BIOME (Bacillus subtilis MB40), a probiotic supplement, on bloating, gas and abdominal discomfort symptoms in otherwise healthy adults.

Phase

0.08 miles

Learn More »

Efficacy of a LRC (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults

To investigate the effect of a supplement capsule containing LRC (L. reuteri NCIMB 30242), taken twice daily with lunch and dinner (NLT 2.5E9 CFU per dose), versus placebo capsule on serum low density lipoprotein (LDL)-cholesterol in otherwise healthy hypercholesterolemic adults after 9 weeks of product consumption.

Phase N/A

0.08 miles

Learn More »

A Study Evaluating Good Idea on Glucose Homeostasis in a Healthy Population

A crossover design to evaluate the safety and efficacy of GoodIdea TM (trademark) on glucose homeostasis in a healthy population. Eligible participants will be given either the GoodIdea drink or placebo and a standardized meal and will consume both in approximately 15 minutes. Blood will be drawn at several time ...

Phase

0.08 miles

Learn More »

Effect of Efpeglenatide on Cardiovascular Outcomes

The estimated study duration per participant is up to approximately 36 months.

Phase

0.08 miles

Learn More »

AMAZ-02 Effect on Exercise ToLerance in Healthy Overweight Middle Aged Subjects (ATLAS Trial)

This is a Phase 2 randomized, double-blind, placebo-controlled study enrolling 90 healthy, overweight, middle aged subjects (30 placebo, 30 low dose and 30 high dose AMAZ-02 intervention), 40-65 years of age, who are otherwise healthy. AMAZ-02, a food derived ingredient, will be given as a daily oral dose for 4 ...

Phase N/A

0.08 miles

Learn More »

A Study to Evaluate the Efficacy of the Investigational Products on Complete Spontaneous Bowel Movements in Participants Who Normally Have 3 Complete Spontaneous Bowel Movements Per Week But Are Otherwise Healthy

Low and High doses of Actazin and Livaux will be compared against a control formula and placebo to evaluate how each investigational study product effects complete spontaneous bowel movements in healthy adults that currently experience less than or equal to 3 complete spontaneous bowel movements per week. During the 28-day ...

Phase

0.08 miles

Learn More »

Ability of Beta-glucan Supplementation to Augment Immune Function

At screening, an informed consent form will be given to the potential volunteer. They will be required to read the information and will be given the opportunity to seek more information if needed or provided with the option of taking the consent form home to review prior to making their ...

Phase N/A

0.08 miles

Learn More »

Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)

Acute kidney injury (AKI) is a common and devastating complication of critical illness. Once AKI is established, treatment is largely supportive and no intervention has been found to restore kidney function or improve overall survival. Renal replacement therapy (RRT), usually in the form of hemodialysis, is frequently needed to manage ...

Phase

0.12 miles

Learn More »

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

The purpose of this trial is to test if a marketed drug for advanced prostate cancer (FIRMAGON) can reduce the risk of cardiovascular complications as compared to another marketed drug for advanced prostate cancer (LUPRON DEPOT) in patients with prostate cancer and cardiovascular disease.

Phase

0.12 miles

Learn More »

CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases

Subjects will be required to have acceptable baseline 3TMRI imaging of carotid arteries. Subjects meeting all eligibility criteria will be randomized to receive CER-001 or placebo (2:1 randomization scheme). Randomized subjects will return weekly for a total of 9 infusions and then biweekly for an additional 20 infusions. 3TMRI imaging ...

Phase

0.12 miles

Learn More »